Roman high and low avoidance rats differ in their response to chronic olanzapine treatment at the level of body weight regulation, glucose homeostasis, and cortico-mesolimbic gene expression (Q47188807)

From Wikidata

Revision as of 21:37, 3 May 2024 by KrBot (talk | contribs) (‎Set a claim value: title (P1476): Roman high and low avoidance rats differ in their response to chronic olanzapine treatment at the level of body weight regulation, glucose homeostasis, and cortico-mesolimbic gene expression)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published in August 2017

Language	Label	Description	Also known as
English	Roman high and low avoidance rats differ in their response to chronic olanzapine treatment at the level of body weight regulation, glucose homeostasis, and cortico-mesolimbic gene expression	scientific article published in August 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/28892416

Roman high and low avoidance rats differ in their response to chronic olanzapine treatment at the level of body weight regulation, glucose homeostasis, and cortico-mesolimbic gene expression (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/28892416

1

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/28892416

Anton J. W. Scheurink

4

object named as

Anton Jw Scheurink

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/28892416

Gertjan van Dijk

5

object named as

Gertjan van Dijk

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/28892416

author name string

Gretha J Boersma

2

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/28892416

Kellie Lk Tamashiro

3

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/28892416

language of work or name

0 references

publication date

1 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/28892416

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/28892416

31

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/28892416

11

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/28892416

1437-1452

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/28892416

Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Role of leptin in the neuroendocrine response to fasting

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Dopamine D1 receptor gene expression decreases in the nucleus accumbens upon long-term exposure to palatable food and differs depending on diet-induced obesity phenotype in rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Altered basal and stimulated accumbens dopamine release in obese OLETF rats as a function of age and diabetic status

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Coping style predicts the (in)sensitivity for developing hyperinsulinemia on a high fat diet in rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

The passive coping Roman Low Avoidance rat, a non-obese rat model for insulin resistance.

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Intermittent treatment with olanzapine causes sensitization of the metabolic side-effects in rats.

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Routine exercise ameliorates the metabolic side-effects of treatment with the atypical antipsychotic drug olanzapine in rats.

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Radioreceptor binding profile of the atypical antipsychotic olanzapine

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha 1-adrenergic and muscarinic receptors in vivo in rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Involvement of neuropeptide systems in schizophrenia: human studies

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Insulin resistance following continuous, chronic olanzapine treatment: an animal model

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

A parametric analysis of olanzapine-induced weight gain in female rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities.

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Correlated behavioral traits in rats of the Roman selection lines

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Biochemical parameters of dopaminergic and GABAergic neurotransmission in the CNS of Roman high-avoidance and Roman low-avoidance rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Can an early weight management program (WMP) prevent olanzapine (OLZ)-induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four- and 48-week results from a 6-month randomized trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Stressful environmental stimuli increase extracellular DOPAC levels in the prefrontal cortex of hypoemotional (Roman high-avoidance) but not hyperemotional (Roman low-avoidance) rats. An in vivo voltammetric study

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

The development of various somatic markers is retarded in an animal model for schizophrenia, namely apomorphine-susceptible rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Roman high- and low-avoidance rats: present status of the Swiss sublines, RHA/Verh and RLA/Verh, and effects of amphetamine on shuttle-box performance.

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Regional 5-HT analysis in Roman high- and low-avoidance rats following MAO inhibition.

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Amphetamine-induced stereotypic responses in Roman high- and Roman low-avoidance rats.

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Olanzapine causes hypothermia, inactivity, a deranged feeding pattern and weight gain in female Wistar rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

A low TSH profile predicts olanzapine-induced weight gain and relief by adjunctive topiramate in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Deficits of mesolimbic dopamine neurotransmission in rat dietary obesity

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Two distinctive apomorphine-induced phenotypes in the Roman high- and low-avoidance rats.

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

GABAergic and dopaminergic transmission in the brain of Roman high-avoidance and Roman low-avoidance rats.

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Differential neurochemical properties of central serotonergic transmission in Roman high- and low-avoidance rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: a comparative study in the Roman high- and low-avoidance rat lines

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Behavioural effects of acute and repeated cocaine treatments: a comparative study in sensitisation-prone RHA rats and their sensitisation-resistant RLA counterparts

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects.

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Decreased serum prolactin in opiate withdrawal and dopaminergic hyperactivity

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Reduced ethanol response in the alcohol-preferring RHA rats and neuropeptide mRNAs in relevant structures

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Divergent anatomical pattern of D1 and D3 binding and dopamine- and cyclic AMP-regulated phosphoprotein of 32 kDa mRNA expression in the Roman rat strains: Implications for drug addiction.

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Effects of intracerebroventricular (ICV) olanzapine on insulin sensitivity and secretion in vivo: an animal model.

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Olanzapine reduces physical activity in rats exposed to activity-based anorexia: possible implications for treatment of anorexia nervosa?

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Association of DRD2 and ANKK1 polymorphisms with prolactin increase in olanzapine-treated women

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Genetic associations of prolactin increase in olanzapine/fluoxetine combination-treated patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

The nature of dopamine dysfunction in schizophrenia and what this means for treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Dampened Mesolimbic Dopamine Function and Signaling by Saturated but not Monounsaturated Dietary Lipids

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

5-HT(2A) and mGlu2 receptor binding levels are related to differences in impulsive behavior in the Roman Low- (RLA) and High- (RHA) avoidance rat strains

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Insulin resistance in brain alters dopamine turnover and causes behavioral disorders.

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome.

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Prolactin activation of the long form of its cognate receptor causes increased visceral fat and obesity in males as shown in transgenic mice expressing only this receptor subtype

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

A transgenic model of visceral obesity and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Weight changes over time in adults treated with the oral or depot formulations of olanzapine: a pooled analysis of 86 clinical trials

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Impulsivity characterization in the Roman high- and low-avoidance rat strains: behavioral and neurochemical differences

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Prolactin/Leptin interactions in the control of food intake in rats.

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Effects of systemic and central prolactin injections on food intake, weight gain, and estrous cyclicity in female rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Prepulse inhibition predicts spatial working memory performance in the inbred Roman high- and low-avoidance rats and in genetically heterogeneous NIH-HS rats: relevance for studying pre-attentive and cognitive anomalies in schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Differential effects of antipsychotic and propsychotic drugs on prepulse inhibition and locomotor activity in Roman high- (RHA) and low-avoidance (RLA) rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Methods and models for metabolic assessment in mice

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Effects of antidepressants on the performance in the forced swim test of two psychogenetically selected lines of rats that differ in coping strategies to aversive conditions

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Effects of chronic antidepressant treatments in a putative genetic model of vulnerability (Roman low-avoidance rats) and resistance (Roman high-avoidance rats) to stress-induced depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Forearm metabolism in obesity and its response to intra-arterial insulin. Characterization of insulin resistance and evidence for adaptive hyperinsulinism

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Reduced accumbens dopamine in Sprague-Dawley rats prone to overeating a fat-rich diet

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Genetic Rat Models of Schizophrenia-Relevant Symptoms

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Multi-receptor binding profile of clozapine and olanzapine: a structural study based on the new beta2 adrenergic receptor template

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Divergent stress responses and coping styles in psychogenetically selected Roman high-(RHA) and low-(RLA) avoidance rats: behavioural, neuroendocrine and developmental aspects

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Neuroendocrine correlates of emotional reactivity and coping in male rats from the Roman high (RHA/Verh)- and low (RLA/Verh)-avoidance lines

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Gender-specific programming of insulin secretion and action

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Effect of Serum Leptin on Weight Gain Induced by Olanzapine in Female Patients with Schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Olanzapine affects locomotor activity and meal size in male rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

The acute effects of olanzapine on ghrelin secretion, CCK sensitivity, meal size, locomotor activity and body temperature

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Forced and voluntary exercise counteract insulin resistance in rats: the role of coping style

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Individual variation in the (patho)physiology of energy balance

1 reference

https://api.crossref.org/works/10.1177%2F0269881117724749

21 January 2018

Identifiers

10.1177/0269881117724749

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/28892416

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/28892416

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47188807&oldid=2143947395"